Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.99 USD | +3.95% | +78.37% | +55.34% |
31/05 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
31/05 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CALTX Stock
- CALT Stock
- Charts Calliditas Therapeutics AB